泰格医药 (300347.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(泰格医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度每股收益(元) -1.001.001.00--1.001.00
 单季度销售毛利率(%) 33.0041.0040.0040.0038.0041.0041.0039.00
 单季度销售净利率(%) 7.0032.0044.0031.0030.0025.0042.0032.00
 单季度净资产收益率ROE(%) 1.002.004.003.002.002.004.003.00
 单季度总资产净利率ROA(%) -2.003.002.002.002.003.002.00
单季度财务摘要:
 单季度营业总收入(元) 1,733,561,523.001,939,627,566.001,906,278,996.001,804,571,375.001,679,452,625.001,811,809,605.001,776,350,279.001,817,858,959.00
 单季度营业总成本(元) 1,411,938,158.001,422,161,050.001,359,734,128.001,360,291,377.001,283,997,669.001,275,535,160.001,257,376,511.001,339,634,777.00
 单季度营业收入(元) 1,733,561,523.001,939,627,566.001,906,278,996.001,804,571,375.001,679,452,625.001,811,809,605.001,776,350,279.001,817,858,959.00
 单季度营业利润(元) 175,216,285.00713,126,484.00967,700,005.00630,897,783.00581,391,277.00520,086,941.00826,538,962.00654,381,329.00
 单季度利润总额(元) 174,063,643.00715,324,322.00968,082,965.00631,062,128.00579,376,314.00526,135,869.00823,862,932.00656,002,309.00
 单季度净利润(元) 122,079,872.00619,756,979.00839,764,332.00568,325,660.00499,491,016.00454,608,403.00743,655,508.00573,970,499.00
 单季度归属母公司股东的净利润(元) 145,245,559.00491,267,424.00819,881,913.00568,455,093.00401,893,282.00412,654,717.00673,587,238.00518,416,799.00
 单季度经营活动产生的现金流量(元) 477,793,460.00297,603,226.00346,533,036.0028,508,219.00532,115,662.00466,294,235.0056,012,333.00303,078,663.00
 单季度投资活动产生的现金流量(元) 58,280,106.00-883,944,929.00-161,047,098.00-547,512,822.00-378,724,763.00-902,462,037.00-212,643,067.00-1,295,535,996.00
 单季度筹资活动产生的现金流量(元) -482,667,302.00-146,208,961.00318,908,961.00302,161,242.0015,486,642.00356,616,296.00-95,932,107.00533,083,081.00
 单季度现金及现金等价物净增加(元) 39,992,553.00-736,222,874.00541,385,525.00-227,954,721.0098,474,051.00-13,130,342.00-219,905,839.00-461,114,663.00

前瞻产业研究院